Jiten Kothadia, MD
Transplant Hepatology · Memphis, TNNPI 1245636596
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,200 of the $5,661 with a category attached, or 74.2%. Mirum Pharmaceuticals, Inc. accounts for 78.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $4,466 and has fallen 91.6% since, to $375 in 2025.
Across 31 payments — averaging $182.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$4K
- Johnson & Johnson$286
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$208
- Madrigal Pharmaceuticals$175
- Novo Nordisk$170
- Janssen Scientific Affairs, LLC$113
- plus $284 from 6 others
Across 14 payments — averaging $3079.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharma Europe Ltd.$22K
- Intercept Pharmaceuticals, Inc.$9K
- Gilead$7K
- AbbVie$5K
What the payments were for
- Consulting fees$4,20074%
- Food & beverage$1,37724%
- Education$841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 4 | $4,424 |
| Johnson & Johnson | 5 | $286 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $208 |
| Madrigal Pharmaceuticals | 2 | $175 |
| Novo Nordisk | 3 | $170 |
| Janssen Scientific Affairs, LLC | 1 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $112 |
| Gilead | 5 | $68 |
| Mallinckrodt Hospital Products Inc. | 1 | $41 |
| Lilly USA, LLC | 1 | $23 |
| Celltrion USA Inc. | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$249
- XIFAXAN$208
- RESMETIROM$146
How this compares
Too few transplant hepatology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in Memphis
- Andrew ScangaNashville$45K
- Manhal IzzyNashville$25K
- Ashley SpannNashville$21K
- Suzanne SharptonNashville$2K
- Roman PerriNashville$2K
- Bindu BetapudiCollierville$881
- Hannah KimNashville$502
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.